Feasibility and acceptability of nationwide HPV vaccine introduction in Senegal: Findings from community-level cross-sectional surveys, 2020.
Autor: | Doshi RH; Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States Of America., Casey RM; Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States Of America.; CDC Foundation, Atlanta, Georgia, United States Of America., Adrien N; Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States Of America.; CDC Foundation, Atlanta, Georgia, United States Of America., Ndiaye A; Expanded Programme on Immunization, Ministry of Health and Social Action, Dakar, Senegal., Brennan T; Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States Of America.; CDC Foundation, Atlanta, Georgia, United States Of America., Roka JL; Division of Global Health Protection, Centers for Disease control and Prevention, Dakar, Senegal., Bathily A; Unicef, Dakar, Senegal., Ndiaye C; PATH, Dakar, Senegal., Li A; Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States Of America.; CDC Foundation, Atlanta, Georgia, United States Of America., Garon J; Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States Of America.; CDC Foundation, Atlanta, Georgia, United States Of America., Badiane O; Expanded Programme on Immunization, Ministry of Health and Social Action, Dakar, Senegal., Diallo A; World Health Organization, Dakar, Senegal., Loharikar A; Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States Of America. |
---|---|
Jazyk: | angličtina |
Zdroj: | PLOS global public health [PLOS Glob Public Health] 2022 Apr 06; Vol. 2 (4), pp. e0000130. Date of Electronic Publication: 2022 Apr 06 (Print Publication: 2022). |
DOI: | 10.1371/journal.pgph.0000130 |
Abstrakt: | In Senegal, cervical cancer is the most common cancer among women and the leading cause of morbidity and mortality from all cancers. In 2018, Senegal launched a national human papillomavirus (HPV) vaccination program with Gavi, the Vaccine Alliance (Gavi), support. HPV vaccination was incorporated into the national immunization program as a two-dose schedule, with a 6-12-month interval, to nine-year-old girls via routine immunization (RI) services at health facilities, schools and community outreach services throughout the year. During February to March 2020, we conducted interviews to assess the awareness, feasibility, and acceptability of the HPV vaccination program with a cross-sectional convenience sample of healthcare workers (HCWs), school personnel, community healthcare workers (cHCWs), parents, and community leaders from 77 rural and urban health facility catchment areas. Participants were asked questions on HPV vaccine knowledge, delivery, training, and community acceptability of the program. We conducted a descriptive analysis stratified by respondent type. Data were collected from 465 individuals: 77 HCW, 78 school personnel, 78 cHCWs, 152 parents, and community leaders. The majority of HCWs (83.1%) and cHCWs (74.4%) and school personnel (57.7%) attended a training on HPV vaccine before program launch. Of all respondents, most (52.5-87.2%) were able to correctly identify the target population. The majority of respondents (60.2-77.5%) felt that the vaccine was very accepted or accepted in the community. Senegal's HPV vaccine introduction program, among the first national programs in the African region, was accepted by community stakeholders. Training rates were high, and most respondents identified the target population correctly. However, continued technical support is needed for the integration of HPV vaccination as a RI activity for this non-traditional age group. The Senegal experience can be a useful resource for countries planning to introduce the HPV vaccine. Competing Interests: The authors have declared that no competing interests exist. (Copyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.) |
Databáze: | MEDLINE |
Externí odkaz: |